MiniVax Enters into Exclusive Agreement with University of Rochester

9 years ago

New Orleans-based MiniVax specializes in the research and development of novel treatments for opportunistic infections, specifically, at the moment, for Pneumocystis pneumonia (PCP). The company has announced its new ...